Epstein Files

EFTA01394761.pdf

dataset_10 PDF 159.8 KB Feb 4, 2026 1 pages
GLDUS140 Lawrence Hirsch GP-led transactions can present an attractive risk-reward profile Glendower Capital has been active since 2007 in this space GP-Led transactions have significantly evolved over the last 5 years - Deals in the early days were often associated with (quasi) zombie GPs and were not always crafted in the best interest of existing LPs - Today, quality managers are proactively providing liquidity options to their LPs, often with an advisor retained to validate the process GP-led opportunities can present a number of advantages over a traditional acquisition of a LP interest - An accretive and complementary strategy to the mainstream secondary dealflow - Glendower has developed an extensive track record' over 15 transactions with gross c.1.6x MOIC / 22% Gross IRR2 - In-depth due diligence on GPs and their teams - In-depth due diligence on concentrated portfolios, including onsite meetings with underlying companies' management teams - Bespoke design of a new fund and its terms to provide full re-alignment of interests between the GP and Glendower: Budgeted fees, significant GP co-investment, and ratcheted carried interest structure - Incentivisation / protection of specific individuals within the GP that are key to generate value in the existing portfolio Negative governance rights, including veto rights on add-on investments, recapitalizations, etc. - Limited to no use of leverage / deferred structures - underwriting returns based on attractive entry price and portfolio value creation t I) As ct September 3 2017. Performance figures have been criculaed based on tea re-audited performance results and should be read and revieeed in constiction vrkh the -important Inforrnatr.i.n" and 'Wes to the Investment Performance' sections of this presentation, I he 'Notes to Investment Perfomtanee section in particular includes. among other things. a description of the terms used in the tables above and sets forth imrxgrard guidelleas and limaatiors este the nerformanoe described alone Past performance rag a isrediction of the blurs Derto4reterte. (2 Please refer to the overall tiansaction summaries for SOF, SOF O, SOF II and SOF III on pages 43. 45 and 47. Glendower STRICTLY CONFIDENTIAL Capital CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0100803 CONFIDENTIAL SDNY_GM_00246987 EFTA01394761

Entities

0 total entities mentioned

No entities found in this document

Document Metadata

Document ID
7956b0e5-e0f5-4071-b095-0d81c57c7c60
Storage Key
dataset_10/2549/EFTA01394761.pdf
Content Hash
2549e436436d93fd5a6e46d59b09b401
Created
Feb 4, 2026